Ocata Therapeutics Inc fka OCAT

[rocky301]

elysse,

Science side is progressing fine, imo. Clinical trials are long and in
most cases I don't see ACT as far advanced as what I see posted. The preliminary results were very good and bode well for moving on in trials keeping in mind they are very early results with questions yet to be answered but will be in due time.

Corporate side has made improvements with the 3 new BOD's which should help going forward. The share structuring is detrimental, soon to be having a 2B share float is the reason we are where we are. As stated prior, my hopes they due whatever it takes to change that...I don't see ACT getting just value or recognition fumbling around on the OTC...all, imo..thanks